HomeLPCN • NASDAQ
add
Lipocine Inc
Previous close
$7.29
Day range
$7.32 - $8.00
Year range
$2.52 - $12.37
Market cap
56.06M USD
Avg Volume
107.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.15M | -67.19% |
Operating expense | 3.66M | 88.15% |
Net income | -2.37M | -232.99% |
Net profit margin | -206.92 | -505.41% |
Earnings per share | — | — |
EBITDA | -2.50M | -260.20% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.93M | -30.98% |
Total assets | 17.01M | -24.45% |
Total liabilities | 2.53M | 67.11% |
Total equity | 14.48M | — |
Shares outstanding | 7.30M | — |
Price to book | 3.10 | — |
Return on assets | -38.03% | — |
Return on capital | -43.04% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.37M | -232.99% |
Cash from operations | -2.92M | -271.54% |
Cash from investing | 1.57M | 106.52% |
Cash from financing | 2.65M | — |
Net change in cash | 1.30M | -47.02% |
Free cash flow | -2.35M | -304.58% |
About
Founded
1997
Headquarters
Website
Employees
14
